Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by kelvin777on Nov 15, 2015 12:46pm
109 Views
Post# 24293080

RE:RE:Concordia Healthcare: Baby Valeant, More like Baby Majin Buu

RE:RE:Concordia Healthcare: Baby Valeant, More like Baby Majin Buu
Marcel7 wrote: Thanks for sharing. Love the drug by drug description and breakdown. I am curious about their $44 forward price target given that they are using a very low p/e to arrive at that, any higher multiple and it would be trading significantly higher. I do have a question for you. Who or what is Majin Buu and what do you mean by the reference? That reference or inference from it is totally lost on me. Google it, something from anime? My impression is that you are saying much better than Valeant. Thanks! Marcel <blockquote class="BBQuote"> <div> <cite>kelvin777 wrote:</cite> https://docs.google.com/document/d/1aoTzWTHAsssaQDGNi9f-1V-_cpAc1c_xSwGanAE3bhw/edit</div> </blockquote> <br /> <br />


Marcel7: I am not sure why he reference to a Cartoon Character. As for the PT of $44. I don't get it either. All I know is that it will double from here within a year time frame. It has grown to the extent that it will be big enough for more institutionals to invest in. The thing I like about the article is how the drugs breakdown is worth noting.
Mark Thompson said he will buy back shares and he will. This will be a re-assuring for long term investors. I only buy stocks that has management back up with what they say.  I never thought it was possible to buy back shares under $40. With Valeant mess, it created this opportunity. Patience is key.
<< Previous
Bullboard Posts
Next >>